CEPOLYCLONAL REGULATORY T CELL (CEPOLYTREGS) IMMUNOTHERAPY IN ISLET TRANSPLANTATION

Registry ID

PRO00117578

Source registry

HEALTH_CANADA

Status

Ongoing

Study type

INTERVENTIONAL

Sponsor

GOVERNORS OF THE UNIVERSITY OF ALBERTA

Start date

2024-05-21

Last update

2022-05-05

Conditions

• ISLET TRANSPLANTATION

Related clinical trials

• POLYCLONAL REGULATORY T CELL (POLYTREG) IMMUNOTHERAPY IN ISLET TRANSPLANTATION
• CLINICAL STUDY USING ANTIAGING GLYCOPEPTIDE (PKX-001) IN ISLET TRANSPLANTATION
• "IMPROVING SINGLE DONOR SUCCESS RATE IN CLINICAL ISLET TRANSPLANTATION USING ALPHA-1 ANTITRYPSIN (ARALAST NP)."
• A PHASE 2/3, MULTICENTER, RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED PARALLEL ASSIGNMENT STUDY TO ASSESS THE EFFICACY AND SAFETY OF REPARIXIN IN PANCREATIC ISLET AUTO-TRANSPLANTATION,

View on source registry